Dermtech, Inc. (DMTK) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Constellation Alpha Capital Corp.

CIK: 1651944 Ticker: DMTK

View differences made from one to another to evaluate Constellation Alpha Capital Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Constellation Alpha Capital Corp..


Assess how Constellation Alpha Capital Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Constellation Alpha Capital Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: DMTK
CIK: 1651944
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-258318
Submitted to the SEC: Mon Sep 30 2019 10:40:06 AM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Monday, September 30, 2019
Industry: Medical Laboratories
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: